Search results
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 1 day agoKeytruda plus vibostolimab, its investigational anti-TIGIT antibody, as adjuvant treatment for...
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma ...
Benzinga via AOL· 2 days agoAlso Read: Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook. Data...
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Clinical Trials Arena via Yahoo Finance· 1 day agoMSD recently reported that its Phase III KEYNOTE-B21 trial of Keytruda plus chemotherapy in patients...
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters via Yahoo News· 2 days agoThis is the latest setback for the experimental drug, vibostolimab, and the related promising new...
Merck halts research on combo drug for skin cancer
Becker’s Hospital Review· 2 days agotreatment for skin cancer patients in a late-stage study, the drugmaker said May 13. Merck was evaluating the use of the investigational immunotherapy vibostolimab ...
Merck stopped a clinical trial for its experimental skin cancer drug after a high rate of side...
Quartz· 2 days agoMerck announced Monday that it is pulling the plug on its phase 3 trial of an experimental...
Merck stops skin cancer combination therapy testing in late-stage study
Reuters· 2 days ago, opens new tab has discontinued testing a combination of an experimental antibody-based drug and...
Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations
FierceBiotech· 2 days agoMerck & Co. has bailed early on a phase 3 test of the anti-TIGIT antibody vibostolimab after a high...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoMeanwhile, Moderna is expanding its efforts in cancer treatment. The company is partnered with Merck...
The doctor behind the next big thing in cancer treatment
CNN via AOL· 6 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...